ArticleJournal of cancer research and clinical oncology2011

Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation.

Yusuf Baran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.